Tacrine

Tacrine is a parasympathomimetic and a centrally acting cholinesterase inhibitor (anticholinesterase). It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease, and was first synthesised at the Department of Pharmacology at the University of Sydney.

Clinical uses

Tacrine was the prototypical cholinesterase inhibitor for the treatment of Alzheimer's disease. Its clinical effectiveness was hindered by poor oral bioavailability and considerable adverse drug reactions (including nausea, diarrhoea, urinary incontinence, and hepatotoxicity) such that few patients could tolerate therapeutic doses. Indeed there is some doubt as to its efficacy in humans at all. Other newer cholinesterase inhibitors, such as donepezil, are now preferred over tacrine.

Sources

  • Brenner, G. M. (2000). Pharmacology. Philadelphia, PA: W.B. Saunders Company. ISBN 0-7216-7757-6

 

<< PreviousWord BrowserNext >>
lee killough
starship yorktown
click beetle
gund arena
bane (god)
sterreichische bundessportorganisation
lee killough (programmer)
moving light
washington square park
sin tax
kid 'n play
btx (computers)
california state highway 152
slow wave
washington square, philadelphia
seminex
dead three
starship constitution
pyridostigmine
brown daily herald
german football league
saint louis art museum
washington square
jack hutton
iyachtu xvim
symbolic analysis laboratory
women's international squash players association
dwight chapin
kaoss pad
concordia senior college
echothiophate
bay park square
wispa
savona
jochi
german bowl
dead god (dungeons & dragons)
diisopropyl fluorophosphate
wbzx
electronic counter counter measures
helbreath
wlvq
taipei economic and cultural office
list of indoor arenas